Evidence map›Paper›PMID 42897239›Full record

ArticleHeart and vessels2026

Factors associated with serum GDF-15, iron deficiency and lower hemoglobin levels in patients with chronic heart failure and healthy elderly people.

Taira Fukuda, Seiko Tokoi, Riichi Nishikawa, Takaaki Hasegawa, Kan Kondo, Ryo Kayashima, Kaori Kono, Shu Inami, Hirohisa Amano, Takuo Arikawa and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Taira FukudaDepartment of Health and Nutrition, University of Human Arts and Sciences, 1288 Magome, Iwatsuki-ku, Saitama-shi, Saitama, 339-8539, Japan. taira_fukuda@human.ac.jp.ORCID http://orcid.org/0000-0002-2710-2125
Seiko TokoiDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Riichi NishikawaDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Takaaki HasegawaDepartment of Medical KAATSU Training, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Kan KondoDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Ryo KayashimaDepartment of Fundamental Nursing, Dokkyo Medical University School of Nursing, Tochigi, Japan.
Kaori KonoDepartment of Fundamental Nursing, Dokkyo Medical University School of Nursing, Tochigi, Japan.
Shu InamiDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Hirohisa AmanoDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Takuo ArikawaDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Hiroshi YagiDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Suomi YamaguchiDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Masashi SakumaDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Shigeru ToyodaDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Toshiaki NakajimaDepartment of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.

Funding

Japan Society for the Promotion of Science London 19H03981Japan Society for the Promotion of Science London 20K11259Japan Society for the Promotion of Science London 22H03457Japan Society for the Promotion of Science London 24K14354
6 · The paper itself

Abstract

backgroundCoexistent chronic heart failure and iron deficiency is frequently encountered in clinical practice and affects prognosis. We investigated factors associated with serum growth differentiation factor (GDF)-15, iron deficiency and lower hemoglobin levels in patients with heart failure and healthy elderly individuals. METHODS AND

resultsBlood tests were performed on 90 patients with heart failure (aged 75.0 ± 10.7 years) and 73 healthy elderly individuals (aged 76.3 ± 6.4 years). Serum GDF-15, tumor necrosis factor (TNF) α, N-terminal pro-brain natriuretic peptide (NT-proBNP), and hepcidin concentrations were measured using enzyme-linked immunosorbent assay. Left atrial volume index (LAVI) was measured by echocardiography. Hemoglobin (Hb) in healthy elderly individuals correlated with serum iron and hepcidin. In contrast, Hb in patients with heart failure correlated with serum iron and GDF-15. Serum GDF-15 concentration in healthy elderly subjects correlated with estimated glomerular filtration rate, serum iron, and hepcidin. In contrast, in patients with heart failure, it correlated with NT-proBNP and TNFα. In patients with heart failure, serum iron correlated with LAVI.

conclusionsLower hemoglobin levels in patients with heart failure might be associated with elevated serum GDF-15 due to higher serum NT-proBNP and inflammation, as well as iron deficiency. In contrast, lower hemoglobin levels in healthy elderly individuals might involve lower serum iron and hepcidin levels. Lower serum iron concentration was suggested to be involved in left atrial remodeling in patients with heart failure.

Indexed as

Atrial remodelingChronic heart failureGDF-15InflammationIron deficiency

Identifiers

PMID42897239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.